Other
A1M Pharma
develops and commercializes medical applications based on the endogenous protein A1M... Read moreA1M Pharma
develops and commercializes medical applications based on the endogenous protein A1M... Read moreEst. Annual Revenue
<$1M
Est. Employees
<10
News
Sep 23, 2019
Cision
A1M Pharma: Redeye initiates coverage of A1M Pharma
Apr 08, 2019
FinanzNachrichten
A1M Pharma: Nasdaq Stockholm AB: New equity right for trading, A1M Pharma AB TO (129/19)
Nov 22, 2018
4-traders
A1M Pharma: A1M Pharma : receives observation status on Nasdaq First North
Sep 20, 2018
4-traders
A1M Pharma: A1M Pharma : re-submits application to the Swedish Medical Products Agency to conduct clinical trial with ROSgard
Aug 17, 2018
BioPortfolio
A1M Pharma: A1M Pharma AB A1M Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12042018 Prices from USD $250
Aug 15, 2018
BioPortfolio
A1M Pharma: A1M Pharma to prioritize the indication acute kidney injuries in further development of ROSgard on the basis of positive preclinical data
Aug 14, 2018
BioPortfolio
A1M Pharma: AIM Pharma appoints CMO as clinic nears for ROSgard kidney protection drug
Apr 19, 2018
FinanzNachrichten
A1M Pharma: Nasdaq Stockholm AB: Last day of trading in paid subscription shares (BTA) of A1M Pharma AB (134/18)
Mar 21, 2018
BioPortfolio
A1M Pharma: A1M Pharma AB A1M Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 19022018 Prices from USD $250
Mar 06, 2018
FinanzNachrichten
A1M Pharma: Nasdaq Stockholm AB: Trading in subscription rights and paid subscription shares in A1M Pharma AB (publ) (66/18)
A1M Pharma Competitors
1
2
3
4
5
6
7
8
9
10